Effect of Omega-3 Fatty Acid Supplementation on Dry-AMD Progression — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Effect of Omega-3 Fatty Acid Supplementation on Dry-AMD Progression — Stella

Home/Age-Related Macular Degeneration/

View on ClinicalTrials.gov

Recruiting

Back to Age-Related Macular Degeneration trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

China

Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai

Key details

Sponsor

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Enrollment target

~24 participants

Started

October 2025

Primary completion

March 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

50 Years – 85 Years

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.